Alexion Pharmaceuticals, Inc Logo
About Us | Careers | Contact Us
banner graphic

Press Releases

Print Print page | Email Email page


= Add Release to Briefcase
All Releases
View Summary Alexion Extends Its Commitment to a Green Footprint Through Its Ambitious New Solar Energy System
Jun 19, 2009
PDF 11.3 KB Add to Briefcase
View Summary Alexion's Soliris(R) Receives 2009 Prix Galien France for Most Innovative Drug for Rare Disease
Jun 10, 2009
PDF 15.8 KB Add to Briefcase
View Summary Alexion to Present at the Jefferies & Co. 3rd Annual Healthcare Conference
Jun 10, 2009
PDF 7.1 KB Add to Briefcase
View Summary New Research Presented at EHA Congress Shows That Soliris(R) Significantly Reduced Hemolysis in Never-Transfused Patients with PNH
Jun 7, 2009
PDF 19.6 KB Add to Briefcase
View Summary Alexion to Present at Investor Conferences
Jun 3, 2009
PDF 7.5 KB Add to Briefcase
View Summary New Study Results Verify That PNH Cells Are Found in Majority of Patients with Bone Marrow Failure Syndromes
May 29, 2009
PDF 16.4 KB Add to Briefcase
View Summary Researchers to Report on the Investigational Use of Alexion's Soliris(R) (Eculizumab) to Prevent Antibody-Mediated Rejection in High-Risk Kidney Transplant Patients
May 28, 2009
PDF 11.7 KB Add to Briefcase
View Summary Alexion Reports First Quarter 2009 Results
Apr 23, 2009
PDF 24.2 KB Add to Briefcase
View Summary Alexion Pharmaceuticals to Report First Quarter 2009 Results on April 23, 2009
Apr 9, 2009
PDF 7.3 KB Add to Briefcase
View Summary Alexion Submits NDA in Japan for Soliris(R) (eculizumab) as a Treatment for Patients with PNH
Apr 1, 2009
PDF 16.0 KB Add to Briefcase
View Summary Alexion to Present at the 4th Annual Citi Biotech Day
Mar 25, 2009
PDF 7.2 KB Add to Briefcase
View Summary Alexion to Present at the Cowen and Company 29th Annual Health Care Conference
Mar 11, 2009
PDF 7.2 KB Add to Briefcase
View Summary Alexion Joins NORD and EURORDIS in Supporting the Goals of Rare Disease Day
Feb 27, 2009
PDF 16.6 KB Add to Briefcase
View Summary Alexion's Soliris(R) (eculizumab) Receives Marketing Approval in Australia for All Patients with PNH
Feb 25, 2009
PDF 15.8 KB Add to Briefcase
View Summary Alexion Reports Fourth Quarter and Full Year 2008 Results
Feb 12, 2009
PDF 28.8 KB Add to Briefcase
View Summary New England Journal of Medicine Publishes Case Reports on the Investigational Use of Soliris(R) (eculizumab) in Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
Jan 29, 2009
PDF 17.0 KB Add to Briefcase
View Summary Alexion's Soliris(R) (eculizumab) Receives Marketing Approval in Canada for All Patients with PNH
Jan 29, 2009
PDF 15.3 KB Add to Briefcase
View Summary Alexion Pharmaceuticals To Report Fourth Quarter and Full Year 2008 Results on February 12, 2009
Jan 12, 2009
PDF 7.1 KB Add to Briefcase
View Summary Soliris(R) Receives Orphan Drug Designation in Japan
Jan 12, 2009
PDF 14.8 KB Add to Briefcase
View Summary Alexion to Present at the 27th Annual JP Morgan Healthcare Conference
Jan 5, 2009
PDF 6.8 KB Add to Briefcase
Showing 1-20 of 116 releases Page: 1 2 3 4 5 6  See Next 20

© Copyright and Terms of Use 1999 - 2006 Alexion Pharmaceuticals. All rights reserved. | Update Policy